Authors
Loading...
Experimental findings reveal that Sf3b1+/K700E hematopoietic stem cells enhance inflammatory cytokines in bone marrow, suggesting new therapeutic targets for MDS.
Henriet et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: